Hongbing Wang
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 25
- Drug-Induced Hepatotoxicity and Protection 5
-
- Hormonal Regulation and Hypertension 15
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 4
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 14
- Virology top 10%
-
- Estrogen and related hormone effects 10
-
- Liver Disease Diagnosis and Treatment 5
-
- Childhood Cancer Survivors' Quality of Life 3
- Co-authors
- Linhao LiHaishan LiTatsuya SueyoshiMasahiko NegishiRick MooreBryan MackowiakTao ChenStephanie Faucette
- Partner nations
- United StatesChinaGermany
In The Last Decade
Hongbing Wang
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 106
- Pharmacology 655
- Endocrinology, Diabetes and Metabolism 295
- Biochemistry 113
- Oncology 362
- Virology 44
Countries citing papers authored by Hongbing Wang
This map shows the geographic impact of Hongbing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Wang more than expected).
Fields of papers citing papers by Hongbing Wang
This network shows the impact of papers produced by Hongbing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Wang. The network helps show where Hongbing Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongbing Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 19 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 29 | |
| 12 | 2016 | 17 | |
| 13 | 2015 | 33 | |
| 14 | 2013 | 48 | |
| 15 | 2012 | 32 | |
| 16 | 2010 | 61 | |
| 17 | 2010 | 63 | |
| 18 | 2009 | 65 | |
| 19 | 2008 | 89 | |
| 20 | 1994 | 6 |
About Hongbing Wang
Hongbing Wang is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (25 papers), Hormonal Regulation and Hypertension (15 papers), Drug Transport and Resistance Mechanisms (14 papers), Estrogen and related hormone effects (10 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). The work is most often cited by research in Pharmacology (655 citations), Endocrinology, Diabetes and Metabolism (295 citations) and Biochemistry (113 citations). Hongbing Wang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Linhao Li, Haishan Li, Tatsuya Sueyoshi, Masahiko Negishi, Rick Moore, Bryan Mackowiak, Tao Chen, Stephanie Faucette, Curtis J. Omiecinski and Edward L. LeCluyse. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.